Scinai Immunotherapeutics annual gross margin
2024
2025
Scinai Immunotherapeutics Gross Margin Growth & History (SCNI)
Scinai Immunotherapeutics's gross margin was −202.29% for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −202.29% | +148897.97 pp |
| 2024 | 2024-12-31 | −149,100.26% | — |
Scinai Immunotherapeutics gross margin trends
Between the periods ended 2024-12-31 and 2025-12-31, Scinai Immunotherapeutics's gross margin increased from −149,100.26% to −202.29%, a change of +148897.97 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗